By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

RespireRx (Formerly Known As Cortex Pharmaceuticals, Inc.) 

15241 Barranca Parkway

Irvine  California  92718  U.S.A.
Phone: 949-727-3157 Fax: 949-727-3657


SEARCH JOBS


Industry
Biotechnology






Company News
RespireRx (RSRX) Announces Positive Results From Phase 2B PACE Study Conducted By The University of Illinois Dronabinol Reduces Symptoms Of Obstructive Sleep Apnea 12/27/2016 7:37:45 AM
RespireRx (RSRX) Announces Data For CX1739 Clinical Study In Opioid Induced Respiratory Depression 12/15/2016 12:51:46 PM
RespireRx (RSRX) Files September 30, 2016 Quarterly Report On Form 10-Q 11/16/2016 12:18:29 PM
RespireRx (RSRX) Retracts Efficacy Data In September 12, 2016 Press Release Announcing Preliminary Top-Line Analysis Of Safety And Efficacy Data From Duke University Phase 2A Clinicial Trial Of CX 1739 10/4/2016 10:27:39 AM
UPDATE - RespireRx (RSRX) Announces Preliminary Top-Line Analysis Of Data From Duke University Phase 2A Clinical Trial Of CX1739 9/13/2016 11:34:20 AM
RespireRx (RSRX) Announces Preliminary Top-Line Analysis Of Data From Duke University Phase 2A Clinical Trial Of CX1739 9/12/2016 12:23:06 PM
RespireRx (RSRX) To Present At Rodman & Renshaw18th Annual Global Investment Conference On September 12, 2016 9/9/2016 11:05:29 AM
RespireRx (RSRX) Announces 1-for-325 Reverse Stock Split 9/2/2016 9:49:56 AM
RespireRx (RSRX) Files June 30, 2016 Quarterly Report On Form 10-Q 8/16/2016 7:18:59 AM
RespireRx  (RSRX) To Present At The Jefferies 2016 Healthcare Conference 6/8/2016 10:27:43 AM
12345678910...
//-->